# A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

> **NCT02950012** · PHASE2 · COMPLETED · sponsor: **BIO-CAT Microbials, LLC** · enrollment: 100 (actual)

## Conditions studied

- Bloating

## Interventions

- **DIETARY_SUPPLEMENT:** OPTI-BIOME™ Bacillus subtilis MB40
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02950012
- **Lead sponsor:** BIO-CAT Microbials, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950012, "A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02950012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*